ATF1 and cancer: Survival analyses in individual cancer cohorts verify the poor prognosis in patients co-expressing nuclear and mitochondrial targets of ATF1/CREB1, confirming the clinical relevance of ATF1 coordinated nucleus-mitochondria program (Supplementary Fig. S8p, q).